A Trial to Compare Antibacterial vs. Placebo Mouthwash to Reduce the Incidence of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men (MSM) Taking HIV Pre-Exposure Prophylaxis (PrEP)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institute of Tropical Medicine, Belgium
The study aims to assess if there is a difference in the incidence rate of gonorrhea, chlamydia and syphilis detected at any site whilst individuals are on daily and pre/post sex Listerine cool mint (LCM) vs. placebo mouthwash.
The study has a double-blind, cross-over design, in which subjects will be screened at the ITM and, if eligible, will be enrolled and randomized to group 1 (LCM) or group 2 (placebo). After 3 months, a crossover will occur and subjects will switch to the other intervention. Each participant will therefore be enrolled for 6 months (2 x 3 months, no wash out period).
Subjects will be recruited from the existing PrEP cohort at the Institute of Tropical Medicine Antwerp. A total of 320 subjects will be recruited (160 in each arm).
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Men aged 18 or more
Enrolled in Belgian PrEP program at ITM
Has had sex with another man in the previous year
Has had a symptomatic or asymptomatic STI (Ct/Ng/syphilis) in the previous 2 years
Willing to be enrolled in the cohort for 6 months and attend 3 monthly follow up visits
Willing to comply with the mouthwash study schema and willing to ask their casual partners to mouthwash pre- and post-sex
Prepared to fill out the online diary once a week
Able and willing to provide written informed consent
You may not be if
Currently using a mouthwash and unwilling to cease use of this mouthwash